INDIANAPOLIS - As the prevalence of diabetes increases, Eli Lilly and Company is making strides to improve the availability of care to patients.
Lilly is increasing its insulin manufacturing capacity and adding two new insulin-cartridge-filling lines to the Indianapolis facility. Those cartridges can be used in insulin pens, which are growing in popularity.
Operations manager for filling, Lyle Fait, said the filling lines will pump 600 cartridge units a minute.
"With diabetes worldwide becoming almost epidemic in terms of the magnitude, this is the supply and demand that we are trying to meet in terms of keeping the global market supplied," Fait said.
Lilly is a global leader in the treatment of diabetes. The company introduced insulin as a treatment in 1923.
Officials said $400 million was being poured into the facilities, which will further Lilly’s pursuit of offering a full range of innovative options to diabetics.
National diabetes statistics show nearly 25.8 million people in the United States have diabetes. As many of seven million of those people are undiagnosed.
Cops Cycling for Survivors finishes 1k-mile ride
For the last two weeks, a group of Hoosiers has been biking across Indiana in support of the families of law enforcement officers killed in…
PHOTOS: Pokemon Go meetup at White River Park
Pokemon Go players gathered at White River State Park Saturday for a day of fun and Pokemon catching.
Kyle Busch takes Brickyard 400 pole
Kyle Busch will try to defend his Brickyard 400 win from the pole Sunday.
Could Indy host the next GOP convention?
After the GOP's big political party in Cleveland, Hoosiers are now asking whether Indianapolis could play host to the Republican National…
IMPD desperately trying to solve two cold cases
IMPD Sgt. Shawn Looper is no stranger to homicides – and as one of the city's top homicide detectives, he's often the one…